NCF2 and systemic lupus erythematosus: The NCF2 variants may disrupt ROS production which is often dysregulated in SLE patients, thus leading to the accumulation of NET debris and auto-antigenicity, altered profile of epitopes selected for presentation, and immune dysregulation (81-84, 87, 88).